ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 697859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 697859; 2) Community: the network communities that were significantly associated with the response to NSC 697859; 3) Molecule: the relationships between components within communities and NSC 697859; 4) MDR: the compounds that were significantly associated with the NSC 697859.

NSC Compound Enrichment Correlation
NSC 681271 1,3,6-Triphenyl-oxazolo(5,4-d)pyrimidin-2',4(1H,3H)-dion 0.0385203205529756 -0.32716141
NSC 685685 3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- 0.0385203205529756 0.31084706
NSC 685875 Null 0.0385203205529756 0.14911105
NSC 129790 Null 0.0396077140933377 -0.01031996
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0396077140933377 -0.0013094977
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0396077140933377 -0.049471029
NSC 39215 Null 0.0396077140933377 0.19708994
NSC 44684 Null 0.0396077140933377 0.39738818
NSC 606499 Camptothecin Derivative 0.0396077140933377 -0.10459201
NSC 615291 Bizelesin 0.0396077140933377 -0.17801849
Total:83  Current:69    [First] [Prev] [Next] [Last]